+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nerve Repair and Regeneration Devices - Global Market Trajectory & Analytics

  • ID: 4805293
  • Report
  • September 2020
  • Region: Global
  • 513 pages
  • Global Industry Analysts, Inc
1 of 2
The global market for Nerve Repair and Regeneration is projected to reach US$12.7 billion by 2025, driven by high incidence of brain disorders and nerve injuries. The human nervous system comprises complex, delicate structures such as the spinal cord, the brain, and peripheral nerves, which are susceptible to different types of injuries. Nerves constitute the most significant cable systems in the human body, performing the crucial job of carrying messages and information to brain and also to other parts of body. Whenever such critical nerves are injured, problems arise in muscles leading to sensation loss. Major types of nerve injuries include Neuropraxia, the physiologic blocking of nerve; Axonotmesis, the anatomic disruption of axon with slight disruption of connective tissue; and Neurotmesis, the anatomic disruption of connective tissue and nerve fibers. These injuries could result in trauma or more serious neurodegenerative diseases such as Parkinson`s disease, Alzheimer`s disease, multiple system atrophy, multiple sclerosis, and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig`s disease).Alzheimer`s, Parkinson`s, Amyotrophic Lateral Sclerosis and multiple sclerosis are diseases that cause injury to the complex, delicate structures of the nervous system. Till date spinal cord injury and peripheral nerve damage are often permanent and incapacitating.

Innovative strategies are required for a shift in the paradigm and advanced treatment of these neurological injuries. But the question as to whether adult neurogenesis isrealstill remains unanswered with several contentious research studies still underway with no definitive answer to this century-long debate. Regrowth or repair of nervous tissues and cells involves generation of new neurons, glia, axons, myelin, or synapses. Gene Therapy is attracting immense research investments for its promise in promoting nerve regeneration and intraneural revascularization is being studied for its role in peripheral nerve regeneration. Newer studies are however dampening hopes by stating that adults produce no new cells in the hippocampus. Nevertheless, hopes of regeneration arecreating lucrative commercial opportunities as the pressure builds for newer and more effective treatment for neurological diseases. As the world awaits for a paradigm-shift in the treatment of neurological injury, neurostimulation and neuromodulation devices and biomaterials remains a massive multi- billiondollar market worldwide. Neurostimulation and neuromodulation devices are currently available solutions to treat a variety of nerve injuries including peripheral nerve injuries. Neurostimulation and neuromodulation methods involve use of specially designed devices to transmit electrical impulses for controlling activity of the central nervous system and the brain. Internal neurostimulation and neuromodulation devices are growing in popularity for their significantly lower risk for post-surgical complications and shorter hospital stays. These include deep brain stimulation (DBS)for Parkinson`s, epilepsy and depression; spinal cord stimulation (SCS) for pain management and spasticity; gastric electrical stimulation (GES) for obesity and gastroparesis; vagus nerve stimulation (VNS) for depression and epilepsy; and sacral nerve stimulation (SNS) for constipation and urinary incontinence disorders. External neurostimulation devices, on the other hand, comprise transcutaneous vagus nerve stimulation (TVNS) for autism, depression, anxiety and age related disorders; transcutaneous electrical nerve stimulation (TENS)for chronic neuropathic pain and fibromyalgia disorders; transcranial magnetic stimulation (TMS)for depression and ADHD; and respiratory electrical stimulation (RES) for improving the respiratory function after spinal cord injury.

Competitors identified in this market include, among others:
  • ABB Ltd.
  • Accuenergy Ltd.
  • Albireo Energy, LLC
  • Eaton Corporation Inc.
  • Emerson Electric Company
  • Fluke Corporation
  • Fuji Electric FA Components & Systems Co., Ltd.
  • GE Grid Solutions
  • Greystone Energy Systems Inc.
  • Littelfuse, Inc.
  • Mitsubishi Electric Corporation
  • Omron Corporation
  • Rockwell Automation, Inc.
  • Samsara Networks, Inc.
  • Schneider Electric SE
  • Siemens AG
  • VaCom Technologies
  • Veris Industries
  • Yokogawa Electric Corporation.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW
  • Nerve Repair and Regeneration Market Set for a Rapid Growth
  • Neurostimulation and Neuromodulation Devices: Largest Product Segment
  • Biomaterials to Exhibit Rapid Growth
  • Nerve Repair and Regeneration Market by Application
  • US and Europe Dominate the Market, Asia-Pacific to Register the Fastest Growth
2. FOCUS ON SELECT PLAYERS
  • Abbott Laboratories, Inc. (USA)
  • AxoGen, Inc. (USA)
  • Boston Scientific Corporation (USA)
  • Integra LifeSciences Corporation (USA)
  • LivaNova, PLC (UK)
  • Medtronic plc (USA)
  • NeuroPace, Inc. (USA)
  • Nevro Corporation.(USA)
  • Orthomed S.A.S. (France)
  • Polyganics B.V. (The Netherlands)
  • Stryker Corporation (U.S.)
  • Synapse Biomedical Inc. (U.S.)
3. MARKET TRENDS & DRIVERS
  • High Incidence of Brain Disorders and Nerve Injuries: Primary Market Driver
  • Annual Incidence of Adult-Onset Neurologic Disorders in the US
  • Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
  • Global Alzheimer's Prevalence by Age Group
  • Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
  • Classification of Nerve Injuries
  • Recent Developments in Spinal Cord Injury Treatment
  • Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
  • Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
  • New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies
  • Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
  • Innovative Nerve Conduits from Stryker
  • Technological Advancements and Product Innovations - A Key Growth Driver
  • Neurostimulation Allows Paralyzed People to Regain Leg Movement
  • Neurostimulator to Treat Neurological Conditions
  • Micro-Implantable Solution for Neurostimulation
  • Parasym™ Device for Neurostimulation
  • Boston Scientific’s Spinal Cord Stimulation Improves Quality of Life
  • Intellis™ Platform Presents Smallest Implantable Neurostimulator
  • Innovation in Deep Brain Stimulation for Parkinson’s Disease
  • Innovations in Spinal Cord Stimulation for Pain
  • Smart Neuromodulation: The Combination of AI and Neuromodulation Technologies
  • New Dynamic Lead Interface Design for Neurostimulator Devices
  • Wireless SCS Neuromodulation Therapy: An Alternative to Traditional SCS System
  • Select Recent Approvals of Neuro-stimulation and Neuromodulation Devices
  • Select Launches in Spinal Cord Stimulation (SCS) Market
  • Select Launches in Deep Brain Stimulation (DBS) Market
  • Select Neurostimulation Devices in Clinical Trials
  • Select Neuromodulation Devices in Clinical Trials
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

CANADA

JAPAN

CHINA

EUROPE

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 35
Note: Product cover images may vary from those shown
Adroll
adroll